News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Leandro Jonata Oliveira: Would you recommend universal germline GT for patients with cancer?
Jul 29, 2024, 02:27

Leandro Jonata Oliveira: Would you recommend universal germline GT for patients with cancer?

Leandro Jonata Oliveira, Medical Oncologist at Grupo Oncoclinicas,  shared a poll on X:

“Tapestry Study: screening using exome Sequencing identified 32% of HBOC and 56% of Lynch Syndrome carriers who did not meet NCCN criteria for genetic testing (GT).

In the scenario of unrestricted access to GT and couseling, would you recommend universal germline GT for patients with cancer?
  • Yes
  • Not
  • Not yet

‘Exome Sequencing Identifies Carriers of the Autosomal Dominant Cancer Predisposition Disorders Beyond Current Practice Guideline Recommendations published in JCO Precision Oncology’

Autors: N. Jewel Samadder, Emily Gay, Vanda Lindpere, Michelle L. Bublitz, Lorelei A. Bandel, Sebastian M. Armasu, Robert A. Vierkant, Matthew J. Ferber, Eric W. Klee, Nicholas B. Larson, Teresa M. Kruisselbrink, Jan B. Egan, Jennifer L. Kemppainen, Jessa S. Bidwell, Jennifer L. Anderson, Tammy M. McAllister, T’Nita S. Walker, Katie L. Kunze, Michael A. Golafshar, Margaret A. Klint, Richard J. Presutti, William V. Bobo, Aleksander Sekulic, Jolene M. Summer-Bolster, Cheryl L. Willman, and Konstantinos N. Lazaridis.”

Leandro Jonata Oliveira

Source: Leandro Jonata Oliveira/X

Aleksander Sekulic cancer Cheryl L. Willman Emily Gay Eric W. Klee exome Sequencing identifies Jan B. Egan Jennifer L. Anderson Jennifer L. Kemppainen Jessa S. Bidwell Jolene M. Summer-Bolster Katie L. Kunze Konstantinos N. Lazaridis Leandro Jonata Oliveira Lorelei A. Bandel Lynch Syndrome Margaret A. Klint Matthew J. Ferber Michael A. Golafshar Michelle L. Bublitz N. Jewel Samadder NCCN Nicholas B. Larson OncoDaily Oncology Richard J. Presutti Robert A. Vierkant Sebastian M. Armasu T'Nita S. Walker Tammy M. McAllister Teresa M. Kruisselbrink Vanda Lindpere William V. Bobo
Special Coverage
Blog
Feb 1, 2025, 09:39
Stephen V Liu: Connecting with friends from the lung cancer community at ITCD2025
Blog
Feb 1, 2025, 09:27
Giselle Sholler: Thrilled to collaborate with Nature’s Toolbox to pioneer personalized RNA vaccines
Blog
Feb 1, 2025, 09:13
9th Annual Conference of ELLOK - "Person Centered Care: From Planning to Implementation"
Insight
Feb 1, 2025, 09:08
Why is Survivorship Passport essential? - PanCare
Blog
Feb 1, 2025, 09:05
Justin Stebbing: Air pollution may protect against skin cancer, but the health risks are far more serious
Blog
Feb 1, 2025, 09:02
Implementing Palliative Care in Karongi District - ACREOL Global
Insight
Feb 1, 2025, 08:57
Mohamed Emam Sobeih: Honored to have my abstract presented in the upcoming ELLC 2025 In Paris
Opinion
Feb 1, 2025, 08:53
Liang Cheng: Is Axillary Lymph Node Dissection Needed?
Opinion
Feb 1, 2025, 08:50
Sharlene Gill: Great summary of best practices to increase wellness and decrease burnout in oncology
Blog
Feb 1, 2025, 08:47
Lavondia Alexander: Grateful to serve as board co-chair of the Atrium Health Cancer Center Community Advisory Board
Blog
Feb 1, 2025, 08:47
Sewanti Limaye: New horizons in oncology at Illuminate - Oncology Townhall 2.0 together
Blog
Feb 1, 2025, 08:46
Adamu Alhassan Umar: Prevention is better, safer and cheaper than cure